Docoh
Loading...

271 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2021 Q3
PRPO Precipio Inc
12 Nov 21
Quarterly report
4:02pm
expanded access to its COVID-19 rapid antibody test by listing on Amazon.com’s healthcare website platform. The antibody test is manufactured in the U.S … on the delivery method (web-portal access or fax) for the patient’s laboratory report, per the contract. Clinical research grants Control of the clinical
10-Q
2021 Q2
PRPO Precipio Inc
12 Aug 21
Quarterly report
4:07pm
in time. As such, the Company recognizes revenue for laboratory testing services at a point in time based on the delivery method (web-portal access … , 2021, the Company expanded access to its COVID-19 rapid antibody test (20 minute) by listing on Amazon.com’s healthcare website platform. The antibody
10-Q
2021 Q1
PRPO Precipio Inc
14 May 21
Quarterly report
4:01pm
(web-portal access or fax) for the patient’s laboratory report, per the contract. Clinical research grants Control of the clinical research services … – COVID Testing On May 3, 2021, the Company expanded access to its COVID-19 rapid antibody test (20 minute) by listing on Amazon.com’s healthcare
DEF 14A
PRPO Precipio Inc
29 Apr 21
Definitive proxy
4:31pm
, 2020 on Form 10-K filed with the SEC on March 29, 2021 (“Annual Report”). The Notice contains instructions on how to access those documents and to cast … . Under rules issued by the Securities and Exchange Commission (the “SEC”), we are providing access to our proxy materials both by sending you this full
8-K
EX-1.01
PRPO Precipio Inc
2 Apr 21
Entry into a Material Definitive Agreement
3:00pm
) access to assets is permitted only in accordance with management’s general or specific authorization; (iv) the recorded accountability for assets … to state a material fact relates to information supplied by the Company or the Sales Agent, the intent of the parties and their relative knowledge, access
424B5
5xmpomep
2 Apr 21
Prospectus supplement for primary offering
2:00pm
10-K
jwqp9 8h59
29 Mar 21
Annual report
4:29pm
10-Q
2g794k
13 Nov 20
Quarterly report
4:01pm
10-Q
qob1vw
13 Aug 20
Quarterly report
3:07pm
424B3
njykymc 250nbip1t
7 Jul 20
Prospectus supplement
5:27pm
S-1
lty5av1cf8948shw
26 Jun 20
IPO registration
5:18pm
10-Q
0nq1lsk0h34 owb9qn
14 May 20
Quarterly report
4:05pm
DEFA14A
1dzp3du8
29 Apr 20
Additional proxy soliciting materials
4:34pm
DEF 14A
8dzwa2e
29 Apr 20
Definitive proxy
4:32pm
424B3
xfx1m3ba54
13 Apr 20
Prospectus supplement
4:55pm
S-3/A
en3hak
9 Apr 20
Shelf registration (amended)
1:53pm
S-1/A
5u3xlm
8 Apr 20
IPO registration (amended)
3:41pm
S-3
61l7 23xea5
27 Mar 20
Shelf registration
4:51pm
S-1
ysq3x9l 9gj7ncm
27 Mar 20
IPO registration
4:31pm
10-K
f8pbqu8vf sv
27 Mar 20
Annual report
3:47pm